Cargando…

Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial

Medication overuse headache (MOH) is a severe burden to sufferers and its treatment has few evidence-based indications. The aim of this study is to evaluate efficacy and safety of nabilone in reducing pain and frequency of headache, the number of analgesic intake and in increasing the quality of lif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pini, Luigi Alberto, Guerzoni, Simona, Cainazzo, Maria Michela, Ferrari, Anna, Sarchielli, Paola, Tiraferri, Ilaria, Ciccarese, Michela, Zappaterra, Maurizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2012
Materias:	Clinical Trials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484259/ https://www.ncbi.nlm.nih.gov/pubmed/23070400 http://dx.doi.org/10.1007/s10194-012-0490-1

Ejemplares similares

Impact of continuing or quitting smoking on episodic cluster headache: a pilot survey
por: Ferrari, Anna, et al.
Publicado: (2013)

Comparison of tolerability and efficacy of a combination of paracetamol + caffeine and sumatriptan in the treatment of migraine attack: a randomized, double-blind, double-dummy, cross-over study
por: Pini, Luigi Alberto, et al.
Publicado: (2012)

Basal cutaneous pain threshold in headache patients
por: Zappaterra, Maurizio, et al.
Publicado: (2011)

Can cigarette smoking worsen the clinical course of cluster headache?
por: Tiraferri, I, et al.
Publicado: (2013)

P045. OnabotulinumtoxinA: long term treatment for chronic migraine with medication overuse
por: Guerzoni, Simona, et al.
Publicado: (2015)

Exploration of candidate serum biomarkers potentially related to the chronic pain condition in Medication–overuse headache
por: Pellesi, Lanfranco, et al.
Publicado: (2019)

O015. Evaluation of the genetic polymorphism of the α3 (CHRNA3) and α5 (CHRNA5) nicotinic receptor subunits, in patients with cluster headache
por: Cainazzo, Maria Michela, et al.
Publicado: (2015)

Validation of potential candidate biomarkers of drug-induced nephrotoxicity and allodynia in medication-overuse headache
por: Bellei, Elisa, et al.
Publicado: (2015)

Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy
por: Guerzoni, Simona, et al.
Publicado: (2017)

Addendum: Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy
por: Guerzoni, Simona, et al.
Publicado: (2018)

Discovery by a proteomic approach of possible early biomarkers of drug-induced nephrotoxicity in medication-overuse headache
por: Bellei, Elisa, et al.
Publicado: (2013)

Proteomic analysis of urine in medication-overuse headache patients: possible relation with renal damages
por: Bellei, Elisa, et al.
Publicado: (2011)

Galcanezumab for the treatment of chronic migraine and medication overuse headache: Real‐world clinical evidence in a severely impaired patient population
por: Guerzoni, Simona, et al.
Publicado: (2023)

Nabilone administration in refractory chronic diarrhea: a case series
por: Pellesi, Lanfranco, et al.
Publicado: (2019)

Therapeutical approaches to paroxysmal hemicrania, hemicrania continua and short lasting unilateral neuralgiform headache attacks: a critical appraisal
por: Baraldi, Carlo, et al.
Publicado: (2017)

Medication-overuse headache: an update
por: Sarchielli, Paola
Publicado: (2015)

Detoxification vs non-detoxification before starting an anti-CGRP monoclonal antibody in medication overuse headache
por: Pensato, Umberto, et al.
Publicado: (2022)

A genome-wide analysis in cluster headache points to neprilysin and PACAP receptor gene variants
por: Bacchelli, Elena, et al.
Publicado: (2016)

Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse: a double-blind randomized controlled trial
por: Pijpers, Judith A, et al.
Publicado: (2019)

Drug-dependence behaviour and outcome of medication-overuse headache after treatment
por: Corbelli, Ilenia, et al.
Publicado: (2012)

Long term headache duration is a factor predicting nonresponse to detoxification and advice in medication overuse headache
por: Caproni, Stefano, et al.
Publicado: (2014)

Migraine-specific quality of life questionnaire and relapse of medication overuse headache
por: Caproni, Stefano, et al.
Publicado: (2015)

Safety and Risk of Medication Overuse Headache in Lasmiditan and Second-Generation Gepants: A Rapid Review
por: Lo Castro, Flavia, et al.
Publicado: (2021)

Proteomic research of proteins involved in pain expression in an animal model of chronic pain
por: Bellei, Elisa, et al.
Publicado: (2015)

Risk–benefit and cost–benefit ratio in headache treatment
por: Pini, L. A., et al.
Publicado: (2005)

Topo–kinesthetic memory in chronic headaches. A new test for chronic patients: preliminary report
por: Pini, L. A., et al.
Publicado: (2005)

Non‐Motor Symptoms in Parkinson's Disease are Reduced by Nabilone
por: Peball, Marina, et al.
Publicado: (2020)

Behavioural intervention in medication overuse headache: A concealed double‐blind randomized controlled trial
por: Pijpers, Judith A., et al.
Publicado: (2022)

A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting
por: Ware1, Mark A, et al.
Publicado: (2008)

Predictors of response to erenumab after 12 months of treatment
por: Baraldi, Carlo, et al.
Publicado: (2021)

HDAC3 role in medication consumption in medication overuse headache patients: a pilot study
por: Pisanu, Claudia, et al.
Publicado: (2015)

Medication–overuse headache: pathophysiological insights
por: Calabresi, P., et al.
Publicado: (2005)

Medication-overuse headache: a review
por: Kristoffersen, Espen Saxhaug, et al.
Publicado: (2014)

Preventing and treating medication overuse headache
por: Alstadhaug, Karl B., et al.
Publicado: (2017)

A case of a GH–producing pituitary adenoma associated with a unilateral headache with autonomic signs
por: Marzocchi, N., et al.
Publicado: (2005)

Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline
por: Diener, Hans-Christoph, et al.
Publicado: (2022)

Lack of association between five serotonin metabolism-related genes and medication overuse headache
por: Cevoli, Sabina, et al.
Publicado: (2009)

Abnormal cortical responses to somatosensory stimulation in medication-overuse headache
por: Coppola, Gianluca, et al.
Publicado: (2010)

Psychometric properties of the stagnation scale in medication overuse headache patients
por: Innamorati, Marco, et al.
Publicado: (2015)

Chronic Migraine and Medication Overuse Headache Worsening After OnabotulinumtoxinA Withdrawn Due to the Severe Acute Respiratory Syndrome-Coronavirus-2 Pandemic
por: Baraldi, Carlo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5cjg7rb2u86vt7g6tsvuvlhb5n